Viral Safety of Blood Derivatives by Immune Neutralization
- 1 January 1998
- journal article
- review article
- Published by Wiley in Vox Sanguinis
- Vol. 74 (S1) , 213-217
- https://doi.org/10.1111/j.1423-0410.1998.tb05475.x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Summary of antibody workshop: The Role of Humoral Immunity in the Treatment and Prevention of Emerging and Extant Infectious Diseases.The Journal of Infectious Diseases, 1997
- Neutralization of Cytomegalovirus Virions: The Role of ComplementThe Journal of Infectious Diseases, 1997
- Update on the neutralisation of animal virusesReviews in Medical Virology, 1995
- Antibody-Dependent Enhancement of Infection and the Pathogenesis of Viral DiseaseClinical Infectious Diseases, 1994
- Review of the Hepatitis A Epidemics in Hemophiliacs in EuropeVox Sanguinis, 1994
- Removal and Inactivation of Hepatitis A Virus (HAV) during Processing of Factor VIII ConcentratesVox Sanguinis, 1994
- Solvent/detergent-treated clotting factors and hepatitis A virus seroconversionThe Lancet, 1993
- Hepatitis A and B infections in transfusion‐dependent thalassaemia from endemic areasJournal of Paediatrics and Child Health, 1991
- Contributions to the Optimal Use of Human BloodVox Sanguinis, 1983
- REMOVAL OF HEPATITIS-B-VIRUS INFECTIVITY FROM FACTOR-IX COMPLEX BY HEPATITIS-B IMMUNE-GLOBULINThe Lancet, 1980